TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,200 | -22.7% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $28,723 | +1.2% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $28,388 | -5.1% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $29,898 | -6.6% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | -13.5% | 30,200 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $37,000 | +15.6% | 30,200 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $32,000 | -25.6% | 30,200 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $43,000 | -33.8% | 30,200 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $65,000 | -26.1% | 30,200 | +0.7% | 0.01% | -25.0% |
| Q2 2021 | $88,000 | -22.1% | 30,000 | 0.0% | 0.01% | -27.3% |
| Q1 2021 | $113,000 | -0.9% | 30,000 | 0.0% | 0.01% | -15.4% |
| Q4 2020 | $114,000 | +103.6% | 30,000 | +7.5% | 0.01% | +85.7% |
| Q3 2020 | $56,000 | +27.3% | 27,900 | +39.5% | 0.01% | +16.7% |
| Q2 2020 | $44,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 739,669 | $13,514,000 | 6.33% |
| ACK Asset Management | 749,867 | $13,700,000 | 4.92% |
| CASTLEROCK ASSET MANAGEMENT INC | 26,751 | $489,000 | 4.12% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,297 | $5,651,000 | 2.83% |
| Paradice Investment Management LLC | 348,686 | $6,370,000 | 1.66% |
| Park West Asset Management LLC | 600,770 | $10,976,000 | 1.62% |
| Adirondack Research & Management Inc. | 220,638 | $4,031,000 | 1.50% |
| RK Capital | 375,043 | $6,852,000 | 1.40% |
| KEANE CAPITAL MANAGEMENT INC | 70,000 | $1,279,000 | 1.23% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 953,618 | $17,423,000 | 1.08% |